Bonnie L. Bassler
At a glance: Bonnie L. Bassler is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Jan 8, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 2 sale lines ($1.8M).
Disclosed holdings: about $1.6M of REGN stock: 1,703 shares reported on their latest Form 4 (filed Jan 8, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Bonnie L. Bassler's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 8SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1,5001,703 held (−47%) | $800.00 | $1.2M | +16.6% |
| Nov 24SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 7601,548 held (−33%) | $750.00 | $570K | +24.3% |
- Sell
Director Bonnie L Bassler sold $1.2M of REGN at $800.00 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Bonnie L Bassler sold $570K of REGN at $750.00 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
Follow Bonnie L. Bassler
Get one email when Bonnie L. Bassler files a new purchase or sale. Free.
At most one email a day about Bonnie L. Bassler, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.